nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PSMB1—oviduct—uterine fibroid	0.027	0.0339	CbGeAlD
Bortezomib—CTSG—nipple—uterine fibroid	0.0184	0.0231	CbGeAlD
Bortezomib—CTSG—myometrium—uterine fibroid	0.0158	0.0198	CbGeAlD
Bortezomib—PSMD1—nipple—uterine fibroid	0.0148	0.0186	CbGeAlD
Bortezomib—PSMD2—nipple—uterine fibroid	0.0131	0.0165	CbGeAlD
Bortezomib—PSMB8—nipple—uterine fibroid	0.013	0.0164	CbGeAlD
Bortezomib—PSMD1—myometrium—uterine fibroid	0.0127	0.016	CbGeAlD
Bortezomib—CTSG—uterine cervix—uterine fibroid	0.0123	0.0154	CbGeAlD
Bortezomib—PSMB5—nipple—uterine fibroid	0.0115	0.0145	CbGeAlD
Bortezomib—CTSG—urethra—uterine fibroid	0.0113	0.0142	CbGeAlD
Bortezomib—PSMD2—myometrium—uterine fibroid	0.0113	0.0141	CbGeAlD
Bortezomib—PSMB8—myometrium—uterine fibroid	0.0112	0.014	CbGeAlD
Bortezomib—CTSG—mammalian vulva—uterine fibroid	0.0107	0.0135	CbGeAlD
Bortezomib—CTSG—cardiac atrium—uterine fibroid	0.0103	0.0129	CbGeAlD
Bortezomib—PSMB1—nipple—uterine fibroid	0.0101	0.0126	CbGeAlD
Bortezomib—PSMD1—uterine cervix—uterine fibroid	0.00989	0.0124	CbGeAlD
Bortezomib—PSMB5—myometrium—uterine fibroid	0.00988	0.0124	CbGeAlD
Bortezomib—PSMB2—nipple—uterine fibroid	0.00982	0.0123	CbGeAlD
Bortezomib—PSMA1—uterus—uterine fibroid	0.00981	0.0123	CbGeAlD
Bortezomib—PSMD1—smooth muscle tissue—uterine fibroid	0.00961	0.0121	CbGeAlD
Bortezomib—PSMD1—decidua—uterine fibroid	0.00942	0.0118	CbGeAlD
Bortezomib—PSMD1—urethra—uterine fibroid	0.00909	0.0114	CbGeAlD
Bortezomib—PSMD1—endometrium—uterine fibroid	0.00894	0.0112	CbGeAlD
Bortezomib—PSMA1—female reproductive system—uterine fibroid	0.00882	0.0111	CbGeAlD
Bortezomib—PSMD2—uterine cervix—uterine fibroid	0.00876	0.011	CbGeAlD
Bortezomib—PSMB8—uterine cervix—uterine fibroid	0.0087	0.0109	CbGeAlD
Bortezomib—PSMD1—mammalian vulva—uterine fibroid	0.00865	0.0109	CbGeAlD
Bortezomib—PSMB1—myometrium—uterine fibroid	0.00864	0.0108	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—uterine fibroid	0.00851	0.0107	CbGeAlD
Bortezomib—SLC31A1—nipple—uterine fibroid	0.00851	0.0107	CbGeAlD
Bortezomib—PSMB2—myometrium—uterine fibroid	0.00843	0.0106	CbGeAlD
Bortezomib—PSMD2—decidua—uterine fibroid	0.00834	0.0105	CbGeAlD
Bortezomib—CTSG—vagina—uterine fibroid	0.00831	0.0104	CbGeAlD
Bortezomib—PSMB8—decidua—uterine fibroid	0.00829	0.0104	CbGeAlD
Bortezomib—PSMD1—cardiac atrium—uterine fibroid	0.00828	0.0104	CbGeAlD
Bortezomib—PSMD1—uterus—uterine fibroid	0.00824	0.0103	CbGeAlD
Bortezomib—PSMD2—urethra—uterine fibroid	0.00805	0.0101	CbGeAlD
Bortezomib—PSMA1—female gonad—uterine fibroid	0.00803	0.0101	CbGeAlD
Bortezomib—PSMB8—urethra—uterine fibroid	0.008	0.01	CbGeAlD
Bortezomib—PSMD2—endometrium—uterine fibroid	0.00792	0.00995	CbGeAlD
Bortezomib—PSMB8—endometrium—uterine fibroid	0.00787	0.00989	CbGeAlD
Bortezomib—PSMB5—uterine cervix—uterine fibroid	0.00769	0.00966	CbGeAlD
Bortezomib—PSMD2—mammalian vulva—uterine fibroid	0.00766	0.00962	CbGeAlD
Bortezomib—PSMB8—mammalian vulva—uterine fibroid	0.00761	0.00956	CbGeAlD
Bortezomib—PSMB5—smooth muscle tissue—uterine fibroid	0.00747	0.00938	CbGeAlD
Bortezomib—PSMD2—cardiac atrium—uterine fibroid	0.00734	0.00921	CbGeAlD
Bortezomib—PSMB5—decidua—uterine fibroid	0.00733	0.0092	CbGeAlD
Bortezomib—PSMD2—uterus—uterine fibroid	0.0073	0.00917	CbGeAlD
Bortezomib—SLC31A1—myometrium—uterine fibroid	0.0073	0.00916	CbGeAlD
Bortezomib—PSMB5—urethra—uterine fibroid	0.00707	0.00887	CbGeAlD
Bortezomib—PSMB5—endometrium—uterine fibroid	0.00695	0.00873	CbGeAlD
Bortezomib—PTGS1—oviduct—uterine fibroid	0.0068	0.00855	CbGeAlD
Bortezomib—PSMD1—female gonad—uterine fibroid	0.00674	0.00847	CbGeAlD
Bortezomib—PSMB5—mammalian vulva—uterine fibroid	0.00673	0.00845	CbGeAlD
Bortezomib—PSMB1—uterine cervix—uterine fibroid	0.00672	0.00844	CbGeAlD
Bortezomib—PSMD1—vagina—uterine fibroid	0.0067	0.00841	CbGeAlD
Bortezomib—PSMD2—female reproductive system—uterine fibroid	0.00656	0.00824	CbGeAlD
Bortezomib—PSMB2—uterine cervix—uterine fibroid	0.00656	0.00823	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—uterine fibroid	0.00653	0.0082	CbGeAlD
Bortezomib—PSMB5—cardiac atrium—uterine fibroid	0.00644	0.00809	CbGeAlD
Bortezomib—PSMB5—uterus—uterine fibroid	0.00641	0.00805	CbGeAlD
Bortezomib—PSMB1—decidua—uterine fibroid	0.0064	0.00804	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—uterine fibroid	0.00637	0.008	CbGeAlD
Bortezomib—PSMB2—decidua—uterine fibroid	0.00625	0.00785	CbGeAlD
Bortezomib—PSMB1—urethra—uterine fibroid	0.00618	0.00776	CbGeAlD
Bortezomib—PSMB1—endometrium—uterine fibroid	0.00608	0.00763	CbGeAlD
Bortezomib—PSMB2—urethra—uterine fibroid	0.00603	0.00757	CbGeAlD
Bortezomib—PSMD2—female gonad—uterine fibroid	0.00597	0.0075	CbGeAlD
Bortezomib—PSMD2—vagina—uterine fibroid	0.00593	0.00745	CbGeAlD
Bortezomib—PSMB8—female gonad—uterine fibroid	0.00593	0.00745	CbGeAlD
Bortezomib—PSMB2—endometrium—uterine fibroid	0.00593	0.00745	CbGeAlD
Bortezomib—PSMB8—vagina—uterine fibroid	0.0059	0.00741	CbGeAlD
Bortezomib—PSMB1—mammalian vulva—uterine fibroid	0.00588	0.00738	CbGeAlD
Bortezomib—PSMB2—mammalian vulva—uterine fibroid	0.00574	0.0072	CbGeAlD
Bortezomib—SLC31A1—uterine cervix—uterine fibroid	0.00568	0.00713	CbGeAlD
Bortezomib—PSMB1—cardiac atrium—uterine fibroid	0.00563	0.00707	CbGeAlD
Bortezomib—PSMB1—uterus—uterine fibroid	0.0056	0.00703	CbGeAlD
Bortezomib—PSMB2—cardiac atrium—uterine fibroid	0.00549	0.0069	CbGeAlD
Bortezomib—PSMB2—uterus—uterine fibroid	0.00546	0.00686	CbGeAlD
Bortezomib—PSMB5—female gonad—uterine fibroid	0.00524	0.00658	CbGeAlD
Bortezomib—SLC31A1—urethra—uterine fibroid	0.00522	0.00655	CbGeAlD
Bortezomib—PSMB5—vagina—uterine fibroid	0.00521	0.00654	CbGeAlD
Bortezomib—SLC31A1—endometrium—uterine fibroid	0.00514	0.00645	CbGeAlD
Bortezomib—PSMB1—female reproductive system—uterine fibroid	0.00504	0.00632	CbGeAlD
Bortezomib—SLC31A1—mammalian vulva—uterine fibroid	0.00497	0.00624	CbGeAlD
Bortezomib—PSMB2—female reproductive system—uterine fibroid	0.00491	0.00617	CbGeAlD
Bortezomib—SLC31A1—cardiac atrium—uterine fibroid	0.00476	0.00597	CbGeAlD
Bortezomib—PSMB1—female gonad—uterine fibroid	0.00458	0.00575	CbGeAlD
Bortezomib—PSMB1—vagina—uterine fibroid	0.00455	0.00572	CbGeAlD
Bortezomib—PTGS1—artery—uterine fibroid	0.00451	0.00566	CbGeAlD
Bortezomib—PSMB2—female gonad—uterine fibroid	0.00447	0.00561	CbGeAlD
Bortezomib—PSMB2—vagina—uterine fibroid	0.00444	0.00558	CbGeAlD
Bortezomib—SLC31A1—female reproductive system—uterine fibroid	0.00425	0.00534	CbGeAlD
Bortezomib—SLC31A1—female gonad—uterine fibroid	0.00387	0.00486	CbGeAlD
Bortezomib—SLC31A1—vagina—uterine fibroid	0.00385	0.00483	CbGeAlD
Bortezomib—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.00375	0.0184	CbGpPWpGaD
Bortezomib—PSMA1—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00374	0.0183	CbGpPWpGaD
Bortezomib—PSMD1—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00372	0.0183	CbGpPWpGaD
Bortezomib—PSMD2—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.0037	0.0182	CbGpPWpGaD
Bortezomib—PSMA1—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.0033	0.0162	CbGpPWpGaD
Bortezomib—PSMD1—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00329	0.0161	CbGpPWpGaD
Bortezomib—PSMD2—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00327	0.016	CbGpPWpGaD
Bortezomib—CYP1A2—nipple—uterine fibroid	0.00293	0.00368	CbGeAlD
Bortezomib—PSMA1—B Cell Activation—TNRC6B—uterine fibroid	0.00292	0.0143	CbGpPWpGaD
Bortezomib—PSMD1—B Cell Activation—TNRC6B—uterine fibroid	0.0029	0.0142	CbGpPWpGaD
Bortezomib—CYP1A1—nipple—uterine fibroid	0.00289	0.00363	CbGeAlD
Bortezomib—PSMD2—B Cell Activation—TNRC6B—uterine fibroid	0.00289	0.0142	CbGpPWpGaD
Bortezomib—PSMB5—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00283	0.0139	CbGpPWpGaD
Bortezomib—PSMB2—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00283	0.0139	CbGpPWpGaD
Bortezomib—PSMB1—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00283	0.0139	CbGpPWpGaD
Bortezomib—PSMB8—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00279	0.0137	CbGpPWpGaD
Bortezomib—PTGS1—nipple—uterine fibroid	0.00254	0.00319	CbGeAlD
Bortezomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.0025	0.0123	CbGpPWpGaD
Bortezomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.0025	0.0123	CbGpPWpGaD
Bortezomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.0025	0.0123	CbGpPWpGaD
Bortezomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00247	0.0121	CbGpPWpGaD
Bortezomib—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.0024	0.0118	CbGpPWpGaD
Bortezomib—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.00239	0.0117	CbGpPWpGaD
Bortezomib—PSMB5—B Cell Activation—TNRC6B—uterine fibroid	0.00221	0.0108	CbGpPWpGaD
Bortezomib—PSMB1—B Cell Activation—TNRC6B—uterine fibroid	0.00221	0.0108	CbGpPWpGaD
Bortezomib—PSMB2—B Cell Activation—TNRC6B—uterine fibroid	0.00221	0.0108	CbGpPWpGaD
Bortezomib—PSMB8—B Cell Activation—TNRC6B—uterine fibroid	0.00218	0.0107	CbGpPWpGaD
Bortezomib—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00209	0.0103	CbGpPWpGaD
Bortezomib—CYP1A1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00206	0.0101	CbGpPWpGaD
Bortezomib—PSMA1—Signaling by Wnt—TNRC6B—uterine fibroid	0.00198	0.0097	CbGpPWpGaD
Bortezomib—PSMD1—Signaling by Wnt—TNRC6B—uterine fibroid	0.00197	0.00965	CbGpPWpGaD
Bortezomib—PSMD2—Signaling by Wnt—TNRC6B—uterine fibroid	0.00196	0.00961	CbGpPWpGaD
Bortezomib—CYP1A1—uterine cervix—uterine fibroid	0.00193	0.00242	CbGeAlD
Bortezomib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00192	0.0094	CbGpPWpGaD
Bortezomib—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00189	0.00928	CbGpPWpGaD
Bortezomib—CYP2C8—endometrium—uterine fibroid	0.00189	0.00237	CbGeAlD
Bortezomib—PSMA1—Disease—HPSE2—uterine fibroid	0.00184	0.00901	CbGpPWpGaD
Bortezomib—PSMD1—Disease—HPSE2—uterine fibroid	0.00183	0.00897	CbGpPWpGaD
Bortezomib—PSMD2—Disease—HPSE2—uterine fibroid	0.00182	0.00893	CbGpPWpGaD
Bortezomib—CYP1A1—urethra—uterine fibroid	0.00177	0.00223	CbGeAlD
Bortezomib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00171	0.00839	CbGpPWpGaD
Bortezomib—PTGS1—uterine cervix—uterine fibroid	0.00169	0.00213	CbGeAlD
Bortezomib—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00169	0.00831	CbGpPWpGaD
Bortezomib—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00169	0.00828	CbGpPWpGaD
Bortezomib—CYP1A1—mammalian vulva—uterine fibroid	0.00169	0.00212	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—uterine fibroid	0.00165	0.00207	CbGeAlD
Bortezomib—CYP2C19—vagina—uterine fibroid	0.00162	0.00204	CbGeAlD
Bortezomib—CYP1A1—cardiac atrium—uterine fibroid	0.00162	0.00203	CbGeAlD
Bortezomib—CYP1A1—uterus—uterine fibroid	0.00161	0.00202	CbGeAlD
Bortezomib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00157	0.00772	CbGpPWpGaD
Bortezomib—CYP2C8—female reproductive system—uterine fibroid	0.00157	0.00197	CbGeAlD
Bortezomib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00156	0.00765	CbGpPWpGaD
Bortezomib—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00155	0.00762	CbGpPWpGaD
Bortezomib—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00155	0.00762	CbGpPWpGaD
Bortezomib—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00154	0.00755	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—HPSE2—uterine fibroid	0.00154	0.00755	CbGpPWpGaD
Bortezomib—CYP1A1—PPARA activates gene expression—MED12—uterine fibroid	0.00154	0.00754	CbGpPWpGaD
Bortezomib—PTGS1—endometrium—uterine fibroid	0.00153	0.00192	CbGeAlD
Bortezomib—PSMD1—Metabolism—HPSE2—uterine fibroid	0.00153	0.00751	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—HPSE2—uterine fibroid	0.00152	0.00748	CbGpPWpGaD
Bortezomib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.0015	0.00738	CbGpPWpGaD
Bortezomib—PSMB2—Signaling by Wnt—TNRC6B—uterine fibroid	0.0015	0.00735	CbGpPWpGaD
Bortezomib—PSMB1—Signaling by Wnt—TNRC6B—uterine fibroid	0.0015	0.00735	CbGpPWpGaD
Bortezomib—PSMB5—Signaling by Wnt—TNRC6B—uterine fibroid	0.0015	0.00735	CbGpPWpGaD
Bortezomib—PTGS1—mammalian vulva—uterine fibroid	0.00148	0.00186	CbGeAlD
Bortezomib—PSMB8—Signaling by Wnt—TNRC6B—uterine fibroid	0.00148	0.00725	CbGpPWpGaD
Bortezomib—CYP1A1—female reproductive system—uterine fibroid	0.00144	0.00181	CbGeAlD
Bortezomib—PTGS1—cardiac atrium—uterine fibroid	0.00142	0.00178	CbGeAlD
Bortezomib—CYP2C8—vagina—uterine fibroid	0.00142	0.00178	CbGeAlD
Bortezomib—PTGS1—uterus—uterine fibroid	0.00141	0.00177	CbGeAlD
Bortezomib—PSMB5—Disease—HPSE2—uterine fibroid	0.00139	0.00683	CbGpPWpGaD
Bortezomib—PSMB2—Disease—HPSE2—uterine fibroid	0.00139	0.00683	CbGpPWpGaD
Bortezomib—PSMB1—Disease—HPSE2—uterine fibroid	0.00139	0.00683	CbGpPWpGaD
Bortezomib—CYP2C9—female reproductive system—uterine fibroid	0.00139	0.00175	CbGeAlD
Bortezomib—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00139	0.0068	CbGpPWpGaD
Bortezomib—PSMB8—Disease—HPSE2—uterine fibroid	0.00137	0.00673	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00137	0.0067	CbGpPWpGaD
Bortezomib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00133	0.00654	CbGpPWpGaD
Bortezomib—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00131	0.00645	CbGpPWpGaD
Bortezomib—CYP1A1—female gonad—uterine fibroid	0.00131	0.00165	CbGeAlD
Bortezomib—CYP1A1—vagina—uterine fibroid	0.00131	0.00164	CbGeAlD
Bortezomib—PTGS1—Biological oxidations—CYP17A1—uterine fibroid	0.00128	0.00627	CbGpPWpGaD
Bortezomib—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00128	0.00626	CbGpPWpGaD
Bortezomib—PTGS1—female reproductive system—uterine fibroid	0.00127	0.00159	CbGeAlD
Bortezomib—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00126	0.0062	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—TNRC6B—uterine fibroid	0.00118	0.00577	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—TNRC6B—uterine fibroid	0.00117	0.00574	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—HPSE2—uterine fibroid	0.00117	0.00572	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—HPSE2—uterine fibroid	0.00117	0.00572	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—HPSE2—uterine fibroid	0.00117	0.00572	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—TNRC6B—uterine fibroid	0.00116	0.00571	CbGpPWpGaD
Bortezomib—PTGS1—female gonad—uterine fibroid	0.00116	0.00145	CbGeAlD
Bortezomib—PSMB8—Metabolism—HPSE2—uterine fibroid	0.00115	0.00564	CbGpPWpGaD
Bortezomib—PTGS1—vagina—uterine fibroid	0.00115	0.00144	CbGeAlD
Bortezomib—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00108	0.0053	CbGpPWpGaD
Bortezomib—CYP3A4—female reproductive system—uterine fibroid	0.00106	0.00133	CbGeAlD
Bortezomib—CYP2D6—female reproductive system—uterine fibroid	0.00104	0.00131	CbGeAlD
Bortezomib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.00104	0.00509	CbGpPWpGaD
Bortezomib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00103	0.00505	CbGpPWpGaD
Bortezomib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00101	0.00498	CbGpPWpGaD
Bortezomib—CYP2D6—female gonad—uterine fibroid	0.000949	0.00119	CbGeAlD
Bortezomib—CYP1A1—Biological oxidations—CYP17A1—uterine fibroid	0.0009	0.00442	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—TNRC6B—uterine fibroid	0.000891	0.00437	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000891	0.00437	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—TNRC6B—uterine fibroid	0.000891	0.00437	CbGpPWpGaD
Bortezomib—CYP1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000888	0.00436	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—TNRC6B—uterine fibroid	0.000878	0.00431	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000871	0.00427	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—MED12—uterine fibroid	0.000847	0.00416	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—MED12—uterine fibroid	0.000843	0.00414	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—MED12—uterine fibroid	0.000839	0.00412	CbGpPWpGaD
Bortezomib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000834	0.00409	CbGpPWpGaD
Bortezomib—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	0.000825	0.00405	CbGpPWpGaD
Bortezomib—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000814	0.00399	CbGpPWpGaD
Bortezomib—CYP2C19—Biological oxidations—CYP17A1—uterine fibroid	0.000736	0.00361	CbGpPWpGaD
Bortezomib—CYP2C19—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000726	0.00356	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—TNRC6B—uterine fibroid	0.000713	0.0035	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—TNRC6B—uterine fibroid	0.00071	0.00348	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—TNRC6B—uterine fibroid	0.000709	0.00348	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—TNRC6B—uterine fibroid	0.000706	0.00347	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—TNRC6B—uterine fibroid	0.000706	0.00346	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—TNRC6B—uterine fibroid	0.000702	0.00345	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—PGR—uterine fibroid	0.000702	0.00344	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—PGR—uterine fibroid	0.000699	0.00343	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—PGR—uterine fibroid	0.000695	0.00341	CbGpPWpGaD
Bortezomib—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	0.000677	0.00332	CbGpPWpGaD
Bortezomib—CYP2C9—Biological oxidations—CYP17A1—uterine fibroid	0.000671	0.0033	CbGpPWpGaD
Bortezomib—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000668	0.00328	CbGpPWpGaD
Bortezomib—CYP2C9—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000662	0.00325	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—MED12—uterine fibroid	0.000659	0.00323	CbGpPWpGaD
Bortezomib—PSMA1—Disease—TNRC6B—uterine fibroid	0.000658	0.00323	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—MED12—uterine fibroid	0.000655	0.00322	CbGpPWpGaD
Bortezomib—PSMD1—Disease—TNRC6B—uterine fibroid	0.000655	0.00322	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—MED12—uterine fibroid	0.000652	0.0032	CbGpPWpGaD
Bortezomib—PSMD2—Disease—TNRC6B—uterine fibroid	0.000652	0.0032	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—MED12—uterine fibroid	0.000642	0.00315	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—MED12—uterine fibroid	0.000642	0.00315	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—MED12—uterine fibroid	0.000642	0.00315	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—MED12—uterine fibroid	0.000633	0.00311	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—HPSE2—uterine fibroid	0.000609	0.00299	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000586	0.00288	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	0.000574	0.00282	CbGpPWpGaD
Bortezomib—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000566	0.00278	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CYP17A1—uterine fibroid	0.000551	0.00271	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CYP17A1—uterine fibroid	0.000549	0.00269	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CYP17A1—uterine fibroid	0.000546	0.00268	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—TNRC6B—uterine fibroid	0.00054	0.00265	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—TNRC6B—uterine fibroid	0.00054	0.00265	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—TNRC6B—uterine fibroid	0.00054	0.00265	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—TNRC6B—uterine fibroid	0.000537	0.00264	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—TNRC6B—uterine fibroid	0.000537	0.00264	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—TNRC6B—uterine fibroid	0.000537	0.00264	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—TNRC6B—uterine fibroid	0.000533	0.00261	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—PGR—uterine fibroid	0.000532	0.00261	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—PGR—uterine fibroid	0.000532	0.00261	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—PGR—uterine fibroid	0.000532	0.00261	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—TNRC6B—uterine fibroid	0.00053	0.0026	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—PGR—uterine fibroid	0.000524	0.00257	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—MED12—uterine fibroid	0.000499	0.00245	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—MED12—uterine fibroid	0.000499	0.00245	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—MED12—uterine fibroid	0.000499	0.00245	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TNRC6B—uterine fibroid	0.000499	0.00245	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TNRC6B—uterine fibroid	0.000499	0.00245	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TNRC6B—uterine fibroid	0.000499	0.00245	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—MED12—uterine fibroid	0.000492	0.00242	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TNRC6B—uterine fibroid	0.000492	0.00241	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00049	0.00241	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TNRC6B—uterine fibroid	0.000461	0.00226	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TNRC6B—uterine fibroid	0.000459	0.00225	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TNRC6B—uterine fibroid	0.000457	0.00224	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—PGR—uterine fibroid	0.000456	0.00224	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—PGR—uterine fibroid	0.000454	0.00223	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—PGR—uterine fibroid	0.000452	0.00222	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000443	0.00217	CbGpPWpGaD
Bortezomib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000437	0.00214	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—HPSE2—uterine fibroid	0.000429	0.00211	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CYP17A1—uterine fibroid	0.000418	0.00205	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CYP17A1—uterine fibroid	0.000418	0.00205	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CYP17A1—uterine fibroid	0.000418	0.00205	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000413	0.00203	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CYP17A1—uterine fibroid	0.000412	0.00202	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—HPSE2—uterine fibroid	0.000394	0.00193	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000378	0.00186	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—ESR1—uterine fibroid	0.000375	0.00184	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—ESR1—uterine fibroid	0.000373	0.00183	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—ESR1—uterine fibroid	0.000371	0.00182	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HPSE2—uterine fibroid	0.000351	0.00172	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TNRC6B—uterine fibroid	0.000349	0.00171	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TNRC6B—uterine fibroid	0.000349	0.00171	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TNRC6B—uterine fibroid	0.000349	0.00171	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PGR—uterine fibroid	0.000346	0.0017	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PGR—uterine fibroid	0.000346	0.0017	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PGR—uterine fibroid	0.000346	0.0017	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000346	0.0017	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TNRC6B—uterine fibroid	0.000344	0.00169	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PGR—uterine fibroid	0.000341	0.00167	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000338	0.00166	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HPSE2—uterine fibroid	0.000323	0.00159	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HPSE2—uterine fibroid	0.00032	0.00157	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000317	0.00155	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000308	0.00151	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—ESR1—uterine fibroid	0.000284	0.00139	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—ESR1—uterine fibroid	0.000284	0.00139	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—ESR1—uterine fibroid	0.000284	0.00139	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000283	0.00139	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—ESR1—uterine fibroid	0.00028	0.00137	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HPSE2—uterine fibroid	0.000274	0.00134	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000263	0.00129	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—MED12—uterine fibroid	0.000261	0.00128	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000258	0.00127	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—ESR1—uterine fibroid	0.000244	0.0012	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—ESR1—uterine fibroid	0.000243	0.00119	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—ESR1—uterine fibroid	0.000241	0.00118	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00022	0.00108	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CYP17A1—uterine fibroid	0.000218	0.00107	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000211	0.00104	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—ESR1—uterine fibroid	0.000185	0.000906	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—ESR1—uterine fibroid	0.000185	0.000906	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—ESR1—uterine fibroid	0.000185	0.000906	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MED12—uterine fibroid	0.000184	0.000902	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—ESR1—uterine fibroid	0.000182	0.000893	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MED12—uterine fibroid	0.000169	0.000827	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CYP17A1—uterine fibroid	0.000154	0.000755	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MED12—uterine fibroid	0.00015	0.000738	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP17A1—uterine fibroid	0.000141	0.000692	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MED12—uterine fibroid	0.000138	0.000679	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MED12—uterine fibroid	0.000137	0.000673	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP17A1—uterine fibroid	0.000126	0.000618	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MED12—uterine fibroid	0.000117	0.000575	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP17A1—uterine fibroid	0.000116	0.000568	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP17A1—uterine fibroid	0.000115	0.000564	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP17A1—uterine fibroid	9.81e-05	0.000482	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MED12—uterine fibroid	9.05e-05	0.000444	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	7.57e-05	0.000372	CbGpPWpGaD
